The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings
Conditions
Keywords
Behavior Therapy, methamphetamine
Brief summary
The purpose of this study is...to assess whether placing a substance abuse intervention for HIV+ methamphetamine users within an HIV medical care setting improves rates of follow-up on referral to treatment by primary care physicians; reduces drug use and sexual risk behaviors more than treatment-as-usual; and increases rates of adherence to HIV medication regimens.
Interventions
BEHAVIORALBehavior Therapy
Sponsors
National Institute on Drug Abuse (NIDA)
University of California, Los Angeles
Study design
Primary purpose
TREATMENT
Eligibility
Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the UCLA CARE clinic, aged 18-65 2. Willing to give informed consent and comply with study procedures; 3. Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications; 4. Diagnosed with current methamphetamine abuse as determined by MINI; and 5. Interested in seeking treatment for their methamphetamine abuse and in participating in this research project.
Exclusion criteria
1. Unwilling to give, or withdrawal of, informed consent; 2. Inability to understand nature of study; 3. A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria for current bipolar disorder or a psychotic disorder); 4. Current suicidal ideation or suicide attempt within the past 3 months; and 5. Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI. 6. Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication compliance | — |
| Psychiatric interview | — |
| Sex-risk behavior | — |
| Craving | — |
| Addiction severity | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life | — |
| Depression | — |
Countries
United States
Outcome results
None listed